TrialBreast cancer research and treatment2016

Capecitabine and bevacizumab with or without vinorelbine in first-line treatment of HER2/neu-negative metastatic or locally advanced breast cancer: final efficacy and safety data of the randomised, open-label superiority phase 3 CARIN trial.

A Welt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.